Funded Artificial Intelligence Startups in Sydney
Disclosed round sizes in this Sydney AI slice span from small disclosed checks (Akin’s $100K grant on 2022-06-20; the lowest disclosed amount in the rows)…
Disclosed round sizes in this Sydney AI slice span from small disclosed checks (Akin’s $100K grant on 2022-06-20; the lowest disclosed amount in the rows) up to a single clear outlier: OCR Labs’ $30M Series B on 2022-02-23, which dwarfs the next-largest disclosed rounds (Prospection’s $33M is actually larger, so OCR Labs is not the max; instead the top disclosed amount is Prospection’s $33M Series B on 2021-09-13, and it sits alone as the highest disclosed figure in the list). Most rounds cluster at early-stage labels: the page shows 19 “Series Unknown” entries plus multiple “undisclosed” amounts, so disclosed size signals are incomplete for a sizable share of activity.
Timing also shows front-loaded recency and older tail: the most recent round is Axtec on 2026-06-26 ($690K), while the oldest entries date to 2020-09-01 (Medius Health) and 2020-11-13 (Particular Audience). Across 46 rows, the highest-volume years for disclosed activity are 2021–2022, where several large rounds (e.g., Prospection $33M on 2021-09-13; OCR Labs $30M on 2022-02-23; Omniscient Neurotechnology $30M on 2021-07-14) appear close together compared with later years that include more sub-$12M checks like Sunflower AI’s $20K (2024-07-03).
Most recent rounds
46 shownRelated listings
Frequently asked
What’s the largest disclosed round among these Sydney AI companies, and how unusual is it versus the rest?
The top disclosed amount is Prospection’s $33M Series B on 2021-09-13. Multiple other disclosed rounds are large but mostly below that ceiling (e.g., OCR Labs $30M on 2022-02-23 and Omniscient Neurotechnology $30M on 2021-07-14), while many later entries are in the low-single-digit millions such as Decidr’s $11M (2026-05-06) and Sunflower AI’s $20K (2024-07-03).
How much of the list is missing either stage or disclosed capital, and does that affect interpreting size patterns?
Stage is explicitly “Series Unknown” in 19 of the 46 rows, and “undisclosed” appears as the amount in multiple entries (e.g., Provenioai on 2024-12-11; Visuo on 2024-09-09; Skipped on 2023-10-13). That means comparisons that rely on disclosed amounts skew toward the rows that provide dollar figures.
Where does the activity concentrate in time, based on the round dates shown?
The most recent round shown is Axtec on 2026-06-26, but the densest presence of very large disclosed rounds occurs in 2021–2022 (e.g., Omniscient Neurotechnology $30M on 2021-07-14; Prospection $33M on 2021-09-13; OCR Labs $30M on 2022-02-23). The list also spans back to 2020-09-01 (Medius Health) and 2020-11-13 (Particular Audience), creating an older tail.
Do any stages or stage labels dominate the disclosed pattern in this Sydney AI set?
There isn’t a single stage that consistently aligns with the biggest disclosed checks, because large rounds show up under different labels (e.g., OCR Labs is Series B with $30M on 2022-02-23, while HealthMatch is Series C with $7M on 2022-09-12 and CIM/Calumino are Series A with $7M and $10M on 2022-09-19 and 2022-09-01). Still, early-stage labels appear frequently at the recent end (e.g., Chime Labs Pre-Seed $620K on 2026-04-07; Agentsy Pre-Seed $700K on 2026-02-04).
Are there outliers worth flagging beyond the largest disclosed round?
Yes: Sunflower AI’s $20K (Series Unknown, 2024-07-03) is the smallest disclosed amount in the rows with a dollar figure, sitting far below other sub-$1M entries such as Voqo AI’s $530K (2025-07-13) and Axtec’s $690K (2026-06-26). On the high end, three $30M-class disclosed rounds cluster around 2021–2022 (Omniscient Neurotechnology $30M on 2021-07-14; OCR Labs $30M on 2022-02-23).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.